Home » DE NOVO PHARMACEUTICALS ANNOUNCES NEW THERAPEUTIC FOCUS IN THE AREA OF METABOLIC DISEASES
DE NOVO PHARMACEUTICALS ANNOUNCES NEW THERAPEUTIC FOCUS IN THE AREA OF METABOLIC DISEASES
De Novo Pharmaceuticals Ltd., a world leader in computational drug design, has announced that it is expanding its drug design business to establish a new therapeutic focus in the area of metabolic diseases. To help support this and strengthen the Company's scientific base, it has appointed a new Scientific Advisory Board.
Yahoo News (http://biz.yahoo.com/prnews/060509/ukm006.html?.v=57)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May